Prospective study of inhaled corticosteroid use, cardiovascular mortality, and all-cause mortality in asthmatic women

Chest

Volumn 134, Issue 3, 2008, Pages 546-551

  Camargo Jr , Carlos A ^a,c   Barr, R Graham ^b   Chen, Rong ^a   Speizer, Frank E ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NewYork Presbyterian Hospital   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

All cause mortality; Asthma; Cardiovascular mortality; Inhaled corticosteroids

Indexed keywords

ACETYLSALICYLIC ACID; CORTICOSTEROID; CROMOGLYCATE DISODIUM; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LEUKOTRIENE; THEOPHYLLINE;

ADULT; AGED; ARTICLE; ASTHMA; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG UTILIZATION; FEMALE; GROUPS BY AGE; HEART DISEASE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MORTALITY; NEOPLASM; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; REGISTERED NURSE; SMOKING; STROKE; SYSTEMIC THERAPY;

EID: 51649115549     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.07-3126     Document Type: Article

References (25)

1. American Lung Association. Trends in asthma morbidity and mortality (August 2007). Available at: http://www.lungusa.org/site/pp.asp?c= dvLUK9O0E&b=33347. Accessed July 16, 2008
2. National Asthma Education and Prevention Program. Expert panel report 3: guidelines for the diagnosis and management of asthma (full report). Bethesda, MD: US Department of Health and Human Services, National Institutes of Health, 2007
3. Sin DD, Tu JV. Inhaled corticosteroid therapy reduces the risk of rehospitalization and all-cause mortality in elderly asthmatics. Eur Respir J 2001; 17:380-385
4. Suissa S, Assimes T, Brassard P, et al. Inhaled corticosteroid use in asthma and the prevention of myocardial infarction. Am J Med 2003; 115:377-381
5. Sin DD, Lacy P, York E, et al. Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 170:760-765
6. Cook NR, Buring JE, Ridker PM. The effect of including C-reactive protein in cardiovascular risk prediction models for women. Ann Intern Med 2006; 145:21-29
7. Colditz GA, Hankinson SE. The Nurses' Health Study: lifestyle and health among women. Nat Rev Cancer 2005; 5:388-396
8. Barr RG, Somers SC, Speizer FE, et al. Patient factors and medication guideline adherence among older women with asthma. Arch Intern Med 2002; 162:1761-1768
9. Barr RG, Herbstman J, Speizer FE, et al. Validation of self-reported chronic obstructive pulmonary disease in a prospective cohort study of female registered nurses. Am J Epidemiol 2002; 155:965-971
10. Clark S, Costantino T, Rudnitsky G, et al. Observational study of intravenous versus oral steroids for acute asthma: an example of confounding by severity. Acad Emerg Med 2005; 12:439-445
11. National Asthma Education and Prevention Program. Expert panel report 2: guidelines for the diagnosis and management of asthma. Bethesda, MD: US Department of Health and Human Services, National Institutes of Health, 1997
12. Camargo CA Jr, Weiss ST, Zhang S, et al. Prospective study of body mass index, weight change, and risk of adult-onset asthma in women. Arch Intern Med 1999; 159:2582-2588
13. Jemal A, Ward E, Hao Y, et al. Trends in the leading causes of death in the United States, 1970-2002. JAMA 2005; 294:1255-1259
14. Suissa S, Ernst P. Inhaled corticosteroids: impact on asthma morbidity and mortality. J Allergy Clin Immunol 2001; 107:937-944
15. Albert MA, Danielson E, Rifai N, et al. Effect of statin therapy on C-reactive protein levels: the Pravastatin Inflammation/CRP Evaluation (PRINCE); a randomized trial and cohort study. JAMA 2001; 286:64-70
16. Doganci A, Eigenbrod T, Krug N, et al. The IL-6R α chain controls lung CD4+CD25+ Treg development and function during allergic airway inflammation in vivo. J Clin Invest 2005; 115:313-325
17. Ford ES. Asthma, body mass index, and C-reactive protein among US adults. J Asthma 2003; 40:733-739
18. Takemura M, Matsumoto H, Niimi A, et al. High sensitivity C-reactive protein in asthma. Eur Respir J 2006; 27:908-912
19. Fujita M, Ueki S, Ito W, et al. C-reactive protein levels in the serum of asthmatic patients. Ann Allergy Asthma Immunol 2007; 99:48-53
20. Sin DD, Man SF. Systemic inflammation and mortality in chronic obstructive pulmonary disease. Can J Physiol Pharmacol 2007; 85:141-147
21. Calverley PM, Anderson JA, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007; 356:775-789
22. Löfdahl CG, Postma DS, Pride NB, et al. Possible protection by inhaled budesonide against ischaemic cardiac events in mild COPD. Eur Respir J 2007; 29:1115-1119
23. Barr RG, Woodruff PG, Clark S, et al. Sudden-onset asthma exacerbations: clinical features, response to therapy, and 2-week follow-up: Multicenter Airway Research Collaboration (MARC) investigators. Eur Respir J 2000; 15:266-273
24. Sin DD, Wu L, Anderson JA, et al. Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax 2005; 60:992-997
25. Parimon T, Chien JW, Bryson CL, et al. Inhaled corticosteroids and risk of lung cancer among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 175:712-719